Format

Send to

Choose Destination
N Engl J Med. 2019 May 30;380(22):2169-2171. doi: 10.1056/NEJMe1904362.

Ibrutinib and Venetoclax - Doubling Down on CLL.

Author information

1
From the Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
PMID:
31141640
DOI:
10.1056/NEJMe1904362
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center